Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Finance

Why radiopharma Pentixapharm chose Frankfurt for IPO

Eckert & Ziegler spinout aiming for 4Q24 debut with secondary listing as future option

By Stephen Hansen, Director of Biopharma Intelligence
September 17, 2024 9:54 PM UTC

Why is a therapeutics company in one of the hottest spaces in biotech choosing to go public on the Frankfurt stock exchange and not NASDAQ? It’s because the company doesn’t really have a choice — at least, not yet.

German radioisotope provider Eckert & Ziegler SE (Xetra:EUZ) announced last week that it is spinning out its radiopharma therapeutics and diagnostics subsidiary Pentixapharm Holding AG, with plans for the company to list on the Frankfurt Stock Exchange next quarter. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Pentixapharm GmbH